Sakari Kauppinen

Professor, Department of Clinical Medicine
Professor, The Faculty of Medicine

Phone2047 7994
Emailska@dcm.aau.dk

Frederikskaj 10B, C, FK10B-218
2450 København SV
Denmark

If you made any changes in Pure these will be visible here soon.

Fingerprint The fingerprint consists of automatically generated concepts related to the associated persons. It is updated automatically, when new content is added.

1 Similar Profiles

MicroRNAs Medicine & Life Sciences

Long Noncoding RNA Medicine & Life Sciences

Seeds Medicine & Life Sciences

Small Untranslated RNA Medicine & Life Sciences

Therapeutics Medicine & Life Sciences

Neoplasms Medicine & Life Sciences

Osteogenesis Medicine & Life Sciences

Gene Expression Medicine & Life Sciences

Network Dive into details by clicking on the dots.

Research Output 2010 2019

32 Journal article
5 Conference abstract in journal
4 Patent
3 Review article
2 More
- 2 Comment/debate

1 Citation (Scopus)

Intragenic antagonistic roles of protein and circRNA in tumorigenesis

Guarnerio, J., Zhang, Y., Cheloni, G., Panella, R., Mae Katon, J., Simpson, M., Matsumoto, A., Papa, A., Loretelli, C., Petri, A., Kauppinen, S., Garbutt, C., Petur Nielsen, G., Deshpande, V., Castillo-Martin, M., Cordon-Cardo, C., Dimitrios, S., Clohessy, J. G., Batish, M. & Pandolfi, P. P., 1 Aug 2019, In : Cell Research. 29, 8, p. 628-640 13 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Carcinogenesis

Neoplasms

Proteins

Angiogenesis Inducing Agents

Transcription Factors

Antisense oligomers targeting HOXB-AS3 lon non-coding RNA

Garzon, R., Dorrance, A., Papaioannou, D., Lee, R., Kauppinen, S., Petri, A. & Albæk Thrue, C., 2018, IPC No. C12N 15/ 113 A I, Patent No. WO2018085656, 11 May 2018, Priority date 3 Nov 2016, Priority No. US201662416993P

Research output: Patent

Open Access

Long Noncoding RNA

Untranslated RNA

Disclosure

Acute Myeloid Leukemia

Antisense oligonucleotides (ASOs) designed to inhibit immune checkpoint proteins

Kauppinen, S., Petri, A. & Thrue, C. A., 2018, Patent No. WO2018024849, 8 Feb 2018, Priority date 3 Aug 2016, Priority No. PA201670576

Research output: Patent › Research

Open Access

2 Citations (Scopus)

Development of Locked Nucleic Acid Antisense Oligonucleotides Targeting Ebola Viral Proteins and Host Factor Niemann-Pick C1

Chery, J., Petri, A., Wagschal, A., Lim, S-Y., Cunningham, J., Vasudevan, S., Kauppinen, S. & Näär, A. M., 1 Oct 2018, In : Nucleic Acid Therapeutics. 28, 5, p. 273-284 12 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Antisense Oligonucleotides

Viral Proteins

Viruses

Ebolavirus

Ebola Hemorrhagic Fever

1 Citation (Scopus)

Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche

Tsukamoto, S., Løvendorf, M. B., Park, J., Salem, K. Z., Reagan, M. R., Manier, S., Zavidij, O., Rahmat, M., Huynh, D., Takagi, S., Kawano, Y., Kokubun, K., Thrue, C. A., Nagano, K., Petri, A., Roccaro, A. M., Capelletti, M., Baron, R., Kauppinen, S. & Ghobrial, I. M., 2018, In : Leukemia. 32, 8, p. 1739-1750 12 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Multiple Myeloma

MicroRNAs

Osteogenesis

Bone Marrow

Bone Diseases